Name | VIALAB, OOO |
|---|
INN | 7716570170 |
|---|
KPP | 772401001 |
|---|
OGRN | 1077746332355 |
|---|
OKPO | 99553193 |
|---|
Address | 115409, G.moskva, sh. Kashirskoe, d. D. 68, of. ET 3 POM I KOM 26 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 86 | Core activity | Health service | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | | All types of activities | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 12.02.2007 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 46 po g. Moskve |
|---|
|
VIALAB, OOO (Moscow; INN 7716570170) was registered on 12 Feb 2007. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of VIALAB, OOO - Limited liability companies. Form of ownership of VIALAB, OOO - Private property. Principal activities of VIALAB, OOO: health service (86), wholesale of pharmaceutical goods (46.46), retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2023
Net profit (RAS) of VIALAB, OOO made up 3.72 million RUB over 2023 compared to net loss of 60.46 million RUB over 2022, the company informed. Revenue decreased in the accounting period 4.05 times to 33.33 million RUB from 134.99 million RUB in 2022; cost of goods sold decreased 2.89 times to 48.08 million RUB from 138.72 million RUB; sales loss decreased by 37.20% to 17.21 million RUB from 27.40 million RUB. 2022
Net loss (RAS) of VIALAB, OOO increased by 27.05% to 60.46 million RUB from 47.58 million RUB over 2021, the company informed. Revenue decreased in the accounting period by 18.73% to 134.99 million RUB from 166.09 million RUB in 2021; cost of goods sold decreased by 33.34% to 138.72 million RUB from 208.10 million RUB; sales loss decreased by 42.82% to 27.40 million RUB from 47.92 million RUB. 2021
Net loss (RAS) of VIALAB, OOO increased by 22.74% to 47.58 million RUB from 38.77 million RUB over 2020, the company informed. Revenue increased in the accounting period 1.77 times to 166.09 million RUB from 93.74 million RUB over 2020; cost of goods sold grew 1.62 times to 208.10 million RUB from 128.45 million RUB; sales loss grew by 15.67% to 47.92 million RUB from 41.43 million RUB. 2020
Net loss (RAS) of VIALAB, OOO increased by 12.88% to 38.77 million RUB from 34.34 million RUB over 2019, the company informed. Revenue increased in the accounting period 3.37 times to 93.74 million RUB from 27.81 million RUB over 2019; cost of goods sold grew 2.36 times to 128.45 million RUB from 54.47 million RUB; sales loss grew by 25.96% to 41.43 million RUB from 32.89 million RUB. 2019
Net loss (RAS) of VIALAB, OOO increased 2.11 times to 34.34 million RUB from 16.31 million RUB over 2018, the company informed. Revenue increased in the accounting period 2.76 times to 27.81 million RUB from 10.09 million RUB over 2018; cost of goods sold grew 3.12 times to 54.47 million RUB from 17.46 million RUB; sales loss grew 2.69 times to 32.89 million RUB from 12.23 million RUB. 2018
Net loss (RAS) of VIALAB, OOO dropped over 2018 by 5.01% to 16.31 million RUB from 17.17 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 27.38% to 10.09 million RUB from 7.92 million RUB over 2017; cost of goods sold grew by 9.15% to 17.46 million RUB from 16.00 million RUB; sales loss decreased by 5.25% to 12.23 million RUB from 12.90 million RUB. 2017
Net loss (RAS) of VIALAB, OOO dropped over 2017 by 3.64% to 17.17 million RUB from 17.82 million RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period by 18.14% to 7.92 million RUB from 9.67 million RUB in 2016; cost of goods sold decreased by 12.14% to 16.00 million RUB from 18.21 million RUB; sales loss decreased by 5.15% to 12.90 million RUB from 13.60 million RUB. 2016
Net loss (RAS) of VIALAB, OOO increased by 20.67% to 17.81 million RUB from 14.76 million RUB over 2015, the company informed. Revenue decreased in the accounting period by 21.97% to 9.67 million RUB from 12.39 million RUB in 2015; cost of goods sold decreased by 13.81% to 18.21 million RUB from 21.13 million RUB; sales loss matched the previous year’s result amounting to 13.60 million RUB. 2014
Net loss (RAS) of VIALAB, OOO increased 117.51 times to 21.15 million RUB from 180.00 thousand RUB over 2013, the company informed. Revenue decreased in the accounting period by 7.57% to 4.37 million RUB from 4.73 million RUB in 2013; cost of goods sold grew 4.82 times to 23.03 million RUB from 4.78 million RUB; sales loss grew 476.64 times to 23.83 million RUB from 50.00 thousand RUB. 2013
Net loss (RAS) of VIALAB, OOO dropped over 2013 3.56 times to 180.00 thousand RUB from 641.00 thousand RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period 1.69 times to 4.73 million RUB from 2.81 million RUB over 2012; cost of goods sold grew by 41.13% to 4.78 million RUB from 3.39 million RUB; sales loss decreased 11.64 times to 50.00 thousand RUB from 582.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|